Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This document reports a completed Phase 1 clinical trial of ABT-122 in rheumatoid arthritis. It assesses safety, tolerability and pharmacokinetics after multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ABT-122

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED